Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Más filtros

Medicinas Complementárias
Intervalo de año de publicación
1.
Eur J Neurosci ; 59(7): 1753-1769, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38221503

RESUMEN

The present study aimed to investigate the spontaneous dynamics of large-scale brain networks underlying mindfulness as a dispositional trait, through resting-state electroencephalography (EEG) microstates analysis. Eighteen participants had attended a standardized mindfulness-based stress reduction training (MBSR), and 18 matched waitlist individuals (CTRL) were recorded at rest while they were passively exposed to auditory stimuli. Participants' mindfulness traits were assessed with the Five Facet Mindfulness Questionnaire (FFMQ). To further explore the relationship between microstate dynamics at rest and mindfulness traits, participants were also asked to rate their experience according to five phenomenal dimensions. After training, MBSR participants showed a highly significant increase in FFMQ score, as well as higher observing and non-reactivity FFMQ sub-scores than CTRL participants. Microstate analysis revealed four classes of microstates (A-D) in global clustering across all subjects. The MBSR group showed lower duration, occurrence and coverage of microstate C than the control group. Moreover, these microstate C parameters were negatively correlated to non-reactivity sub-scores of FFMQ across participants, whereas the microstate A occurrence was negatively correlated to FFMQ total score. Further analysis of participants' self-reports suggested that MBSR participants showed a better sensory-affective integration of auditory interferences. In line with previous studies, our results suggest that temporal dynamics of microstate C underlie specifically the non-reactivity trait of mindfulness. These findings encourage further research into microstates in the evaluation and monitoring of the impact of mindfulness-based interventions on the mental health and well-being of individuals.


Asunto(s)
Atención Plena , Humanos , Encéfalo , Electroencefalografía , Mapeo Encefálico/métodos , Personalidad
2.
Calcif Tissue Int ; 101(5): 519-529, 2017 11.
Artículo en Inglés | MEDLINE | ID: mdl-28755011

RESUMEN

Evidence suggests that chiropractic manipulation might exert positive effects in osteoporotic patients. The aim of this study was to evaluate the effects of chiropractic manipulation on bone structure and skeletal muscle in rats with bone loss caused by ovariectomy (OVX). The 6-month old Sprague-Dawley rats at 10 weeks following OVX or sham operation (Sh) did not suffer chiropractic manipulation (NM group) or were submitted to true chiropractic manipulation using the chiropractic adjusting instrument Activator V® three times/week for 6 weeks as follows: Force 1 setting was applied onto the tibial tubercle of the rat right hind limb (TM group), whereas the corresponding left hind limb received a false manipulation (FM group) consisting of ActivatorV® firing in the air and slightly touching the tibial tubercle. Bone mineral density (BMD) and bone mineral content (BMC) were determined in long bones and L3-L4 vertebrae in all rats. Femora and tibia were analyzed by µCT. Mechano growth factor (MGF) was detected in long bones and soleus, quadriceps and tibial muscles by immunohistochemistry and Western blot. The decrease of BMD and BMC as well as trabecular bone impairment in the long bones of OVX rats vs Sh controls was partially reversed in the TM group versus FM or NM rats. This bone improvement by chiropractic manipulation was associated with an increased MGF expression in the quadriceps and the anterior tibial muscle in OVX rats. These findings support the notion that chiropractic manipulation can ameliorate osteoporotic bone at least partly by targeting skeletal muscle.


Asunto(s)
Huesos/metabolismo , Manipulación Quiropráctica , Músculo Esquelético/metabolismo , Animales , Femenino , Factor I del Crecimiento Similar a la Insulina/metabolismo , Osteoporosis/diagnóstico por imagen , Ovariectomía , Ratas , Ratas Sprague-Dawley
5.
Aquat Toxicol ; 98(3): 282-296, 2010 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-20362344

RESUMEN

Thicklip grey mullets Chelon labrosus inhabit coastal and estuarine areas where they can be chronically exposed to commonly released pollutants such as polycyclic aromatic hydrocarbons (PAHs) and perfluorinated compounds. These pollutants can also originate from accidental spills, such as the Prestige oil spill in 2002, which resulted in the release of a heavy fuel oil that affected coastal ecosystems in the Bay of Biscay. Peroxisome proliferation (PP), induced biotransformation metabolism, immunosuppression and endocrine disruption are some of the possible biological effects caused by such chemicals. With the aim of studying the effects of organic toxic chemicals on such biological processes at the transcriptional and at the cell/tissue level, juvenile mullets were exposed to the typical mammalian peroxisome proliferator perfluorooctane sulfonate (PFOS), and to fresh (F) and weathered (WF) Prestige-like heavy fuel oil for 2 and 16 days. First, fragments of genes relevant to biotransformation, immune/inflammatory and endocrine disruption processes were cloned using degenerate primers. Fuel oil elicited a significant PP response as proved by the transcriptional upregulation of palmitoyl-CoA oxidase (aox1), peroxisome proliferator activated receptor alpha (pparalpha) and retinoic X receptor, by the AOX1 activity induction and by the increased peroxisomal volume density. PFOS only elicited a significant induction of AOX1 activity at day 2 and of PPARalpha mRNA expression at day 16. All treatments significantly increased catalase mRNA expression at day 16 in liver and at day 2 in gill. Cyp1a transcription (liver and gill) and EROD activity were induced in fuel oil treated organisms. In the case of phase II metabolism only hepatic glutathione S-transferase mRNA was overexpressed in mullets exposed to WF for 16 days. Functionally, this response was reflected in a significant accumulation of bile PAH metabolites. WF treated fish accumulated mainly high molecular weight metabolites while F exposure resulted in accumulation of mainly low molecular ones. Fuel oil significantly regulated immune response related complement component C3 and hepcidin transcription followed by a significant regulation of inflammatory response related apolipoprotein-A1 and fatty acid binding protein mRNAs at day 16. These responses were accompanied by a significant hepatic inflammatory response with lymphocyte accumulations (IRLA) and accumulation of melanomacrophage centers (MMC). PFOS did not elicit any transcriptional response in the studied biotransformation and immune related genes, although histologically significant effects were recorded in IRLA and MMC. A significant reduction of lysosomal membrane stability was observed in all exposed animals. No endocrine disruption effects were observed in liver while brain aromatase mRNA was overexpressed after all treatments at day 2 and estrogen receptor alpha was downregulated under WF exposure at day 16. These results show new molecular and cellular biomarkers of exposure to organic chemicals and demonstrate that in mullets PP could be regulated through molecular mechanisms similar to those in rodents, although the typical mammalian peroxisome proliferator PFOS and heavy fuel oil follow divergent mechanisms of action.


Asunto(s)
Ácidos Alcanesulfónicos/toxicidad , Biomarcadores/metabolismo , Fluorocarburos/toxicidad , Regulación de la Expresión Génica/efectos de los fármacos , Petróleo/toxicidad , Smegmamorpha/genética , Smegmamorpha/metabolismo , Transcripción Genética/efectos de los fármacos , Animales , Secuencia de Bases , Biotransformación , Disruptores Endocrinos/toxicidad , Exposición a Riesgos Ambientales/efectos adversos , Terapia de Inmunosupresión , Hígado/efectos de los fármacos , Hígado/metabolismo , Lisosomas/efectos de los fármacos , Lisosomas/metabolismo , Peroxisomas/efectos de los fármacos , Peroxisomas/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , España , Factores de Tiempo , Transcripción Genética/genética
6.
Perspect. nutr. hum ; (16): 53-66, jul.-dic. 2006. ilus
Artículo en Español | LILACS | ID: lil-489207

RESUMEN

La homocisteína es un aminoácido sulfurado no esencial, que contiene un grupo tiol y se genera en casi todos los tejidos humanos, como producto del metabolismo de la metionina. Desde el a±o 1990, el estudio de Framingham reconoció la homocisteína (Hcy) como un posible factor de riesgo para enfermedad cardiovascular (ECV) y en el año 2003 lo declaró como factor de riesgo 'emergente'. La hiperhomocisteinemia se define como el aumento de los niveles plasmáticos de Hcy total(unida a proteínas más fracción libre), por encima de 15 μmol/L y se clasifica en tres niveles de severidad, moderado de 15-30 μmol/L, intermedio de 31-100 μmol/L y severo mayor de 100 μmol/L. La hiperhomocisteinemia puede producirse por una deficiencia enzimática en alguno de los pasos de su metabolismo, también se puede presentar por bajos niveles plasmáticos del ácido fólico y las vitaminas B6 y/o B12. La insuficiencia renal puede ser otra causa, debido a que el riñón es la ruta para eliminar la Hcy del plasma. La suplementación dietaria con ácido fólico reduce las concentraciones de Hcy en sangre en un 25 porciento, la suplementación con vitamina B12 en un 7 porciento, mientras que la suplementación con vitamina B6 no tiene efecto en esta disminución. Un estilo de vida saludable, una dieta balanceada con un moderado consumo de café y alcohol y dejar de fumar, contribuye en la reducción de los niveles plasmáticos de Hcy.


Homocysteine is a no essential sulfured aminoacid, that contains a thiol group in its structure. The homocysteineis produced in almost all human tissues for the methionine metabolism. In 1990, The Framingham study, demostrated that homocysteine (Hcy) could be a possible risk factor for cardiovascular disease. Since 2003 Hcy has been considered an “emergent” risk factor. The hiperhomocysteinemia is defined when plasmatic levels of total Hcy is above of 15 μmol/L. It`s classifiedaccording to three severity stages, moderate 15-30 μmol/L, intermediate 31-100 μmol/L and severe, higher than100 μmol/L. hiperhomocysteinemia can be produced by enzymatic deficiency in any of its metabolic routes, andalso due to low plasmatic levels of folic acid, vitamins B6 or B12 and renal failure, because kidney is the mainorgan to eliminate the Hcy from plasma. Folic acid diet supplementation could reduce Hcy blood concentrationabout 25%, and supplementation with vitamin B12 about 7%, however the supplementation with vitamin B6 hasnot shown any effect. Healthy life style, quit smoking, and balanced diet with a moderate consumption of coffee and alcohol may reduce Hcy plasmatic levels.


Asunto(s)
Humanos , Enfermedades Cardiovasculares , Homocisteína , Hiperhomocisteinemia , Factores de Riesgo
7.
Rev. chil. neuro-psiquiatr ; Rev. chil. neuro-psiquiatr;44(1): 15-22, mar. 2006. graf, tab
Artículo en Español | LILACS | ID: lil-476924

RESUMEN

Introducción: En Chile, el consumo de Pasta Base de Cocaína (PBC) se ha asociado a marginalidad y micronarcotráfico. Es posible que en nuestro país exista una población de consumidores de PBC oculta a los estudios de población general y a los servicios sanitarios. El objetivo fue caracterizar una muestra de consumidores de PBC que no han recibido tratamiento reciente por abuso de sustancias utilizando la Entrevista de Acceso Privilegiado. Método: Se entrenaron 9 entrevistadores, con acceso a consumidores de PBC en las comunas de San Joaquín y La Pintana, en la administración de una encuesta sobre patrones de consumo y conductas de riesgo. Resultados: se reclutaron 160 sujetos con una mediana de edad de 21 años (mín: 12; máx: 46) de los cuales 99 fueron hombres (61,9 por ciento). La PBC fue la sustancia primaria de consumo en 136 sujetos (85 por ciento) con una mediana de días de consumo en el último mes de 23 (mín: 1; máx: 30) y una cantidad mediana de consumo de 4,2 gr/día (mín: 1; máx: 75). La edad mediana de inicio de consumo de PBC fue de 16 años (mín: 8; máx: 37). Conclusiones: el patrón de consumo de sustancias de esta muestra no consultante parece ser de mayor severidad que el patrón de consumo de una muestra de población general reportada en el Estudio Nacional de consumo de Sustancias (CONACE 2000) en las mismas comunas. La muestra descrita, o parte de ella, pudiera constituir una población oculta de consumidores de PBC.


Background: In Chile, crack or free-base Cocaine (FBC) use is associated with social isolation and drug traffic. This fact might be conditioning a hidden population of CBP users. The aim of the study was to characterize a sample of out-of-treatment CBP users by means of Privileged Access Interviewing in two districts of Santiago. Methods: Nine privileged access interviewers were trained to administer a questionnaire about substance use patterns and related risk behaviors. Results: 160 CBP users were recruited. The median age of the sample was 21 years (min: 12; max: 46). Gender distribution was 61,9 percent male. CBP was the primary abused substance in 85 percent of the sample. The median days of use in the last month was 23 days (min: 0; max: 30) and the median daily dose in the last month was 4,2 gr/day (min:0; max:75). The median age of onset of CBP use was 16 years (min: 8; max: 37). Conclusions: The pattern of substance use of this out-of-treatment sample seems to be more serious than the pattern of a general population sample reported by a National Survey in the same territorial areas. This sample, or part of it, might be a hidden population of CBP users.


Asunto(s)
Humanos , Masculino , Femenino , Cocaína/efectos adversos , Entrevistas como Asunto , Trastornos Relacionados con Cocaína/complicaciones , Causalidad , Chile , Abuso de Marihuana , Prevalencia , Recolección de Datos/métodos , Sesgo de Selección , Factores Socioeconómicos , Poblaciones Vulnerables
8.
Biofarbo ; 12(12): 3-8, nov. 2004. ilus, tab
Artículo en Español | LILACS | ID: lil-395787

RESUMEN

El presente trabajo es parte del proyecto "Flora Regional como fuente de fármacos antiparasitarios, antifúngicos y anticancerígenos" financiado por la Organización de Estados Americanos (OEA) que se ejecuta en el Instituto de Investigaciones Farmaco Bioquímicas, desde el año 2001. Los principios activos de las partes aéreas de la planta Solanum argentinum, fueron extraídos medianate maceración alchohólica (70 por ciento) y parcialmente purificados por Cromatografia líquida al vació, obteniéndose 9 fracciones con valores de IC50 (concentración inhibitoria del 50 por ciento aceptables (11<10 ug/ml), en la inhibición sobre la maduración de los esquizontes (prueba in vitro). Los valores de IC50 en el Test de Inhibición de la Biomineralización de la Ferriprotoporfirina IX (FBIT), como indicadores de su posible mecanismo de acción también fueron hallados con resultados aceptables (<10mg/ml). Las fracciones activas contra esquizontes se subfraccionaron por cromatografía en columna donde se obtubieron 5 subfracciones activas F3-7, F4-10, F4-12, F5-17 y F5-18.


Asunto(s)
Malaria , Plantas Medicinales , Plasmodium falciparum , Solanum arrebenta , Botánica
9.
Biofarbo ; 12(12): 27-30, nov. 2004. tab
Artículo en Español | LILACS | ID: lil-395791

RESUMEN

Ocho extractos crudos y dos fracciones de alcaloides obtenidos de siete especies vegetales provenientes de la flora colombiana, (abuta grandifolia, Piper holtonii, Acnistus arborescens, Croton leptostachys, Piper cumanense, Acacia farnesiana y Xilopia aromática) fueron evaluadas in vitro frente a tres especies de Leishmania danovanni y Leismania braziliensis y epimastigotes de Trypanosoma cruzi (tulahuen); dos de estas epecies (Acnistus arborescens y Piper cumanense) mostraron alta actividad en los ensayos realizados con valores de concentración inhibitoria 50 (CL50) menores de 12,5 ug/mL; cercanos a los obtenidos con el fármaco de referencia pentamidina 10 ug/mL.


Asunto(s)
Antiparasitarios , Leishmaniasis , Plantas , Tripanocidas , Tripanosomiasis , Bolivia , Colombia , Medicina de Hierbas
13.
Platelets ; 12(8): 456-61, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11798394

RESUMEN

The present case-control study compared 26 HIV+ drug users having persistent thrombocytopenia (TCP<150 000/mm(3)) with 54 available age, gender and HIV CDC classification matched controls with normal platelet counts. Participants were followed longitudinally over a 2-year period (1998-2000), and hematological alterations evaluated in relationship to antiretroviral treatment, drug use and nutritional (selenium) status. Demographic information and medical history, including antiretroviral treatment were obtained. Blood was drawn for complete cell blood count, T lymphocytes and viral load. Sixty-nine percent of the individuals with persistent TCP and 49% of the controls were receiving antiretrovirals. At baseline, no significant differences in CD4 existed between the two groups. Over time, CD4 cell count declined in the cases (P = 0.05) and a significantly higher proportion of the cases (38%) developed AIDS (CD4<200 cell/mm(3)), as compared to the controls (18%, P = 0.004). A high risk for development of thrombocytopenia was observed with specific drug use (heroin 2.96 times, P = 0.0007), selenium levels below 145 microg/l (6 times, P = 0.008), and abnormal liver enzyme (SGOT) levels (2 times, P = 0.002). Together, these results indicate a number of factors that may be sensitive predictors of thrombocytopenia, which, despite antiretroviral treatment, appears to be related to more rapid disease progression in drug users.


Asunto(s)
Infecciones por VIH/complicaciones , Infecciones por VIH/tratamiento farmacológico , Abuso de Sustancias por Vía Intravenosa/complicaciones , Trombocitopenia/complicaciones , Adulto , Terapia Antirretroviral Altamente Activa , Aspartato Aminotransferasas/efectos adversos , Aspartato Aminotransferasas/análisis , Recuento de Linfocito CD4 , Linfocitos T CD8-positivos , Estudios de Casos y Controles , Progresión de la Enfermedad , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Estado Nutricional , Recuento de Plaquetas , Selenio/análisis , Carga Viral
14.
Eur Neurol ; 44(3): 147-52, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11053962

RESUMEN

We assessed the oral system of parkinsonian patients treated with bilateral chronic stimulation of the ventral intermediate nucleus of the thalamus (Vim), and of the subthalamic nucleus (STN) to compare the effects of these procedures on the articulatory organs. Force transducers were used to sample ramp-and-hold force contractions generated by the upper lip, lower lip and tongue at 1- and 2-newton target force levels, as well as maximal force. Fourteen healthy control subjects and 14 parkinsonian patients participated in this study. After an overnight fast the patients were evaluated under two conditions: during bilateral stimulation and 1 h after stopping stimulation. With Vim stimulation, dynamic and static control of the articulatory organs was worsened while with STN stimulation it was greatly improved. The target of stimulation differently influences the oral system and modulates neuronal structures involved in speech.


Asunto(s)
Trastornos de la Articulación/terapia , Dominancia Cerebral/fisiología , Terapia por Estimulación Eléctrica , Enfermedad de Parkinson/terapia , Núcleo Subtalámico/fisiopatología , Núcleos Talámicos Ventrales/fisiopatología , Adulto , Anciano , Trastornos de la Articulación/fisiopatología , Fuerza de la Mordida , Mapeo Encefálico , Terapia por Estimulación Eléctrica/instrumentación , Electrodos Implantados , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neuronas Motoras/fisiología , Neuronas/fisiología , Enfermedad de Parkinson/fisiopatología , Pruebas de Articulación del Habla
15.
Kidney Int ; 48(2): 337-43, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7564100

RESUMEN

Platelet activating factor (PAF) is a potent lipid mediator with a broad range of biologic activities. Experimental evidence suggests that PAF plays a role in the pathogenesis of a variety of inflammatory processes including allograft rejection. In this study, we evaluated the effects of the PAF antagonist BN52021 on the course of renal allograft rejection in a rat model. Kidneys from ACI (RT1a) rats were transplanted into fully allogeneic PVG (RT1c) rat recipients. Animals received 60 mg/kg/day of the PAF antagonist or vehicle beginning immediately prior to the transplantation procedure. In rats treated with the PAF antagonist, allograft GFR and plasma flow were maintained at levels that were significantly greater than controls. Despite the improvement in renal allograft function, BN52021 had no effect on allograft histomorphology and both groups manifested intense inflammatory cell infiltration consistent with acute cellular rejection. PAF antagonism reduced urinary excretion of thromboxane metabolites and decreased thromboxane production by homogenates prepared from kidney allografts. The PAF antagonist had no effect on urinary excretion of peptidoleukotriene metabolites or on the production of LTB4 by allografts. These data support a role for PAF in the pathophysiology of acute renal allograft rejection, and they suggest that the hemodynamic effects of PAF during rejection may be mediated through stimulation of thromboxane A2. In view of the beneficial effects of PAF blockade in rejection as well as recent reports describing efficacy in models of cyclosporine nephrotoxicity, PAF antagonists may have clinical applications in human renal allograft recipients.


Asunto(s)
Diterpenos , Rechazo de Injerto/fisiopatología , Trasplante de Riñón , Factor de Activación Plaquetaria/fisiología , Animales , Ginkgólidos , Tasa de Filtración Glomerular/efectos de los fármacos , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/patología , Lactonas/farmacología , Leucotrieno E4/orina , Masculino , Extractos Vegetales/farmacología , Factor de Activación Plaquetaria/antagonistas & inhibidores , Ratas , Ratas Endogámicas ACI , Ratas Endogámicas , Circulación Renal/efectos de los fármacos , Tromboxano B2/biosíntesis
16.
Prostaglandins ; 48(5): 331-48, 1994 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7855311

RESUMEN

Diets enriched with fish oil (FO) ameliorate kidney disease in the MRL-lpr/lpr murine model of lupus nephritis. Although the mechanisms of this effect are not known, FO is rich in the polyunsaturated fatty acid eicosapentaenoic acid (EPA) which may have profound effects on eicosanoid metabolism. In MRL-lpr/lpr mice, FO feeding reduces renal production of cyclooxygenase metabolites. However, EPA may also affect the metabolism of arachidonate by the 5-lipoxygenase (5-LO) pathway and enhanced production of 5-LO metabolites has been implicated in the pathogenesis of kidney disease in MRL-lpr/lpr mice. We therefore investigated the effects of FO feeding on production of 5-LO metabolites in 20 week old MRL-lpr/lpr mice. After 8 weeks of dietary supplementation with FO, both renal hemodynamic function and glomerular histology were improved compared to safflower oil (SO) controls. Amelioration of kidney disease was associated with alterations in the pattern of leukotriene production by macrophages and kidneys from FO fed mice. There was a significant decrease in the production of leukotriene B4 (LTB4) and tetraene peptidoleukotrienes by peritoneal macrophages isolated from mice given FO compared to control animals. Similarly, dietary supplementation with FO decreased renal production of LTB4. Reduced production of tetraene leukotrienes was accompanied by a modest increase in the production of pentaene leukotrienes by macrophages from FO fed mice. We speculate that this modulation of leukotriene production by FO feeding may have beneficial effects on renal disease in autoimmune nephritis.


Asunto(s)
Aceites de Pescado/farmacología , Leucotrieno B4/biosíntesis , Nefritis Lúpica/metabolismo , Administración Oral , Animales , Araquidonato 5-Lipooxigenasa/biosíntesis , Araquidonato 5-Lipooxigenasa/metabolismo , Aceites de Pescado/administración & dosificación , Hemodinámica , Riñón/efectos de los fármacos , Riñón/enzimología , Riñón/metabolismo , Riñón/fisiopatología , Nefritis Lúpica/enzimología , Nefritis Lúpica/fisiopatología , Ratones , Prostaglandina-Endoperóxido Sintasas/biosíntesis
17.
J Am Acad Dermatol ; 26(3 Pt 2): 423-8, 1992 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-1564149

RESUMEN

BACKGROUND: Pruritic papular eruption (PPE) is a chronic dermatosis frequently seen in human immunodeficiency virus (HIV)-positive patients. UVB phototherapy has been successfully used to treat a similar inflammatory condition (Ofuji disease) as well as pruritus of systemic origin. OBJECTIVE: We describe the successful treatment with UVB of seven of eight patients with PPE. METHODS: Eight HIV-positive patients with PPE were treated. The number of papules in a specified area of skin and the intensity of pruritus were monitored before, during, and after UVB phototherapy given three times a week. Biopsy specimens were taken before and after therapy and systemic immune function was evaluated. RESULTS: Both the number of papules as well as pruritus decreased after UVB treatment in all but one patient. Immunoperoxidase staining showed a relative decrease in CD4+, CD8+, and CD2+ cells in all samples studied except for the patient noted to be unresponsive to the therapy. CONCLUSION: UVB phototherapy is effective in the treatment of patients with PPE. This is associated with a significant decrease in inflammation and number of T cells from various subsets within the dermis, thereby implicating these cells in the pathogenesis of this disorder.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/complicaciones , Prurito/radioterapia , Enfermedades Cutáneas Vesiculoampollosas/radioterapia , Terapia Ultravioleta , Biopsia , Enfermedad Crónica , Humanos , Recuento de Leucocitos , Subgrupos Linfocitarios , Prurito/complicaciones , Prurito/inmunología , Prurito/patología , Piel/patología , Enfermedades Cutáneas Vesiculoampollosas/complicaciones , Enfermedades Cutáneas Vesiculoampollosas/inmunología , Enfermedades Cutáneas Vesiculoampollosas/patología
18.
J Chemother ; 1(1): 39-45, 1989 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2498468

RESUMEN

The aims of this work were to investigate the possible effect of several antimicrobial agents alone and in combinations against 190 clinical isolates of Mycobacterium tuberculosis and 30 isolates of Mycobacterium avium, 30 Mycobacterium fortuitum and 30 Mycobacterium chelonei. The susceptibility was determined in Müller-Hinton agar and Middlebrook 7H 10 agar. For interpretation of the results the minimum inhibitory concentration (MIC) was determined and for the combinations of antimicrobials we used the Fractional Inhibitory Concentration Index (FIC). The possible clinical efficacy was determined by the Inhibitory Quotient. The synergistic effect of several combinations of these compounds was demonstrated.


Asunto(s)
Antibacterianos/farmacología , Mycobacterium/efectos de los fármacos , Antibacterianos/uso terapéutico , Evaluación Preclínica de Medicamentos , Farmacorresistencia Microbiana , Quimioterapia Combinada , Humanos , Infecciones por Mycobacterium/tratamiento farmacológico , Mycobacterium avium/efectos de los fármacos , Mycobacterium tuberculosis/efectos de los fármacos , Micobacterias no Tuberculosas/efectos de los fármacos , Tuberculosis/tratamiento farmacológico
19.
Tubercle ; 68(2): 141-3, 1987 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-3116734

RESUMEN

The in vitro susceptibility of Mycobacterium tuberculosis to a new macrolide antibiotic RU-28965, alone and in combination with rifampicin or isoniazid, was studied by the agar dilution method. At a concentration of 4 mg/l, or lower, of RU-28965, 90% of the strains were inhibited. A synergistic effect with both rifampicin and with isoniazid was demonstrated.


Asunto(s)
Antibióticos Antituberculosos/farmacología , Leucomicinas/farmacología , Mycobacterium tuberculosis/efectos de los fármacos , Combinación de Medicamentos , Evaluación Preclínica de Medicamentos , Isoniazida/farmacología , Pruebas de Sensibilidad Microbiana , Rifampin/farmacología
20.
Annu Rev Med ; 36: 63-71, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-3994328

RESUMEN

In attempting to successfully diagnose and treat people from different cultural dimensions, medical practitioners must supplement theoretical concepts with knowledge about the patients' cultural heritage. In this chapter, the author discusses relevant cultural factors related to the medical management of Cubans, Puerto Ricans, and Mexican Americans residing in the United States.


Asunto(s)
Cultura , Atención a la Salud , Hispánicos o Latinos/psicología , Aculturación , Cuba/etnología , Depresión/diagnóstico , Humanos , Medicina Tradicional , México/etnología , Aceptación de la Atención de Salud , Puerto Rico/etnología , Síndrome , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA